Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Bewarder

Showing results (51-60 of 64) with videos related to

Pageof 7
Sort By:
Journal of Clinical Immunology|January 17, 2024
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting TherapiesMarie-Christin Hoffmann, Giulio Cavalli, Natalie Fadle, et al.
Ejhaem|September 2, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigensTheresa Bock, Moritz Bewarder, Onur Cetin, et al.
Blood|September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphomaLorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Haematologica|July 18, 2020
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphomaLorenz Thurner, Sylvia Hartmann, Moritz Bewarder, et al.
Haematologica|May 4, 2023
B-cell receptor reactivity against <i>Rothia mucilaginosa</i> in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Hemasphere|July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER TrialGerhard Held, Lorenz Thurner, Viola Poeschel, et al.
Blood Advances|February 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Kos, Evi Regitz, et al.
Blood Advances|December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Age Kos, Evi Regitz, et al.
Hemasphere|April 18, 2025
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myelomaJan H Frenking, Christine Riedhammer, Raphael Teipel, et al.
The Lancet. Rheumatology|April 4, 2022
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort studyJochen Pfeifer, Bernhard Thurner, Christoph Kessel, et al.
Pageof 7

Showing results (51-60 of 64) with videos related to

Sort By:
Pageof 7
Journal of Clinical Immunology|January 17, 2024
Autoantibody-Mediated Depletion of IL-1RA in Still's Disease and Potential Impact of IL-1 Targeting TherapiesMarie-Christin Hoffmann, Giulio Cavalli, Natalie Fadle, et al.
Ejhaem|September 2, 2022
B-cell receptors of EBV-negative Burkitt lymphoma bind modified isoforms of autoantigensTheresa Bock, Moritz Bewarder, Onur Cetin, et al.
Blood|September 26, 2018
Hyper-<i>N</i>-glycosylated SAMD14 and neurabin-I as driver autoantigens of primary central nervous system lymphomaLorenz Thurner, Klaus-Dieter Preuss, Moritz Bewarder, et al.
Haematologica|July 18, 2020
Identification of the atypically modified autoantigen Ars2 as the target of B-cell receptors from activated B-cell-type diffuse large B-cell lymphomaLorenz Thurner, Sylvia Hartmann, Moritz Bewarder, et al.
Haematologica|May 4, 2023
B-cell receptor reactivity against <i>Rothia mucilaginosa</i> in nodular lymphocyte-predominant Hodgkin lymphomaLorenz Thurner, Natalie Fadle, Evi Regitz, et al.
Hemasphere|July 10, 2023
Radiation and Dose-densification of R-CHOP in Primary Mediastinal B-cell Lymphoma: Subgroup Analysis of the UNFOLDER TrialGerhard Held, Lorenz Thurner, Viola Poeschel, et al.
Blood Advances|February 24, 2026
Impact of Perforin 1 A91V germ line background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Kos, Evi Regitz, et al.
Blood Advances|December 8, 2025
Impact of Perforin 1 A91V germline background in patients with aggressive B-NHL treated with R-CHOPOnur Cetin, Igor Age Kos, Evi Regitz, et al.
Hemasphere|April 18, 2025
A German multicenter real-world analysis of talquetamab in 138 patients with relapsed/refractory multiple myelomaJan H Frenking, Christine Riedhammer, Raphael Teipel, et al.
The Lancet. Rheumatology|April 4, 2022
Autoantibodies against interleukin-1 receptor antagonist in multisystem inflammatory syndrome in children: a multicentre, retrospective, cohort studyJochen Pfeifer, Bernhard Thurner, Christoph Kessel, et al.
Pageof 7